CDRR is Now Responsible for Oversight of Veterinary Products

On March 14, 2022, the Philippines FDA released Advisory 2022-0159 informing its stakeholders that veterinary products and medical devices will now be handled exclusively by the Center for Drug Regulation and Research (CDRR). The license to operate, product registrations, and other requirements will be based on the Center for Drugs guidance. This includes the manufacture, importation, exportation, distribution, sale, transfer, promotion, advertisement, and sponsorship of medicines, vaccines, biologicals, and medical devices used by veterinarians. These requirements are in accordance with Book I, Article VII Sec. 8 of the rules and regulations implemented by RA No. 9711 – The Food and Drug Administration Act of 2009. The Advisory can be found here.

As of the time of publishing, the CDRR has not provided a specific list of devices or a final vet medical device checklist of requirements. For more information on the medical device registration process, please see our page on the topic here.

Eligibility of Previously Approved Licenses

Applications approved previously by the Department of Agriculture-Bureau of Animal Industry (DA-BAI) will only be honored by the CDRR until September 30, 2022 as long as a new application has been submitted on or before December 31, 2021 as per FDA Circular No. 2021-025: Guidelines for Application of Authorizations at the Food and Drug Administration in the Light of Extended State of Public Health Emergency, dated December 9, 2021.